Microarray-based identification of novel biomarkers in IL-1-mediated diseases

Florence Allantaz, Damien J. Chaussabel, Jacques Banchereau, Virginia Pascual

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Interleukin 1b (IL-1b) is emerging as mediator of a wide range of human diseases. Availability of IL-1 blockers that result in clinical benefits to patients with these diseases is creating a demand for biomarkers to diagnose as well as to predict and follow responses to therapy. Blood gene expression profiling can be used to identify such biomarkers. This review will summarize recent studies in the field and will discuss some of the challenges raised by the use of this technology in biomarker discovery.

Original languageEnglish
Pages (from-to)623-632
Number of pages10
JournalCurrent Opinion in Immunology
Volume19
Issue number6
DOIs
Publication statusPublished - Dec 2007
Externally publishedYes

Fingerprint

Interleukin-1
Biomarkers
Interleukins
Gene Expression Profiling
Technology
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Microarray-based identification of novel biomarkers in IL-1-mediated diseases. / Allantaz, Florence; Chaussabel, Damien J.; Banchereau, Jacques; Pascual, Virginia.

In: Current Opinion in Immunology, Vol. 19, No. 6, 12.2007, p. 623-632.

Research output: Contribution to journalReview article

Allantaz, Florence ; Chaussabel, Damien J. ; Banchereau, Jacques ; Pascual, Virginia. / Microarray-based identification of novel biomarkers in IL-1-mediated diseases. In: Current Opinion in Immunology. 2007 ; Vol. 19, No. 6. pp. 623-632.
@article{d2df3ad5ef85410a90e8aee146290f80,
title = "Microarray-based identification of novel biomarkers in IL-1-mediated diseases",
abstract = "Interleukin 1b (IL-1b) is emerging as mediator of a wide range of human diseases. Availability of IL-1 blockers that result in clinical benefits to patients with these diseases is creating a demand for biomarkers to diagnose as well as to predict and follow responses to therapy. Blood gene expression profiling can be used to identify such biomarkers. This review will summarize recent studies in the field and will discuss some of the challenges raised by the use of this technology in biomarker discovery.",
author = "Florence Allantaz and Chaussabel, {Damien J.} and Jacques Banchereau and Virginia Pascual",
year = "2007",
month = "12",
doi = "10.1016/j.coi.2007.10.003",
language = "English",
volume = "19",
pages = "623--632",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Microarray-based identification of novel biomarkers in IL-1-mediated diseases

AU - Allantaz, Florence

AU - Chaussabel, Damien J.

AU - Banchereau, Jacques

AU - Pascual, Virginia

PY - 2007/12

Y1 - 2007/12

N2 - Interleukin 1b (IL-1b) is emerging as mediator of a wide range of human diseases. Availability of IL-1 blockers that result in clinical benefits to patients with these diseases is creating a demand for biomarkers to diagnose as well as to predict and follow responses to therapy. Blood gene expression profiling can be used to identify such biomarkers. This review will summarize recent studies in the field and will discuss some of the challenges raised by the use of this technology in biomarker discovery.

AB - Interleukin 1b (IL-1b) is emerging as mediator of a wide range of human diseases. Availability of IL-1 blockers that result in clinical benefits to patients with these diseases is creating a demand for biomarkers to diagnose as well as to predict and follow responses to therapy. Blood gene expression profiling can be used to identify such biomarkers. This review will summarize recent studies in the field and will discuss some of the challenges raised by the use of this technology in biomarker discovery.

UR - http://www.scopus.com/inward/record.url?scp=36849057243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849057243&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2007.10.003

DO - 10.1016/j.coi.2007.10.003

M3 - Review article

VL - 19

SP - 623

EP - 632

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 6

ER -